Tolinapant modulates therapeutic response to radiation in high-risk prostate cancer through inhibition of anti-apoptosis proteins
- Mohamed-Smith, L. (Invited speaker)
- LaBonte Wilson, M. (Invited speaker)
Activity: Talk or presentation types › Oral presentation